Correlation Between Mereo BioPharma and UBS Plc
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and UBS Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and UBS Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and UBS plc , you can compare the effects of market volatilities on Mereo BioPharma and UBS Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of UBS Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and UBS Plc.
Diversification Opportunities for Mereo BioPharma and UBS Plc
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mereo and UBS is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and UBS plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UBS plc and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with UBS Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UBS plc has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and UBS Plc go up and down completely randomly.
Pair Corralation between Mereo BioPharma and UBS Plc
Assuming the 90 days trading horizon Mereo BioPharma is expected to generate 1.07 times less return on investment than UBS Plc. In addition to that, Mereo BioPharma is 5.48 times more volatile than UBS plc . It trades about 0.02 of its total potential returns per unit of risk. UBS plc is currently generating about 0.14 per unit of volatility. If you would invest 823,419 in UBS plc on September 5, 2024 and sell it today you would earn a total of 104,281 from holding UBS plc or generate 12.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 99.22% |
Values | Daily Returns |
Mereo BioPharma Group vs. UBS plc
Performance |
Timeline |
Mereo BioPharma Group |
UBS plc |
Mereo BioPharma and UBS Plc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mereo BioPharma and UBS Plc
The main advantage of trading using opposite Mereo BioPharma and UBS Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, UBS Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UBS Plc will offset losses from the drop in UBS Plc's long position.Mereo BioPharma vs. Prudential Financial | Mereo BioPharma vs. Vitec Software Group | Mereo BioPharma vs. International Biotechnology Trust | Mereo BioPharma vs. Pfeiffer Vacuum Technology |
UBS Plc vs. Leverage Shares 3x | UBS Plc vs. WisdomTree Natural Gas | UBS Plc vs. Leverage Shares 3x | UBS Plc vs. GraniteShares 3x Short |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |